findmyKOL

Marina Konopleva, MD, PhD

Enriched profile

Professor of Oncology (Medical Oncology) and Molecular Pharmacology / Cell Biology; Director, Leukemia Program; Co-Director, Blood Cancer Institute (Translational Blood Cancer Institute), Montefiore Einstein Comprehensive Cancer Center; Miriam Mandel Faculty Scholar in Cancer Research · Albert Einstein College of Medicine

ORCID↗NPINone on file
✓ Full profile
RegionNot on fileSpecialtyHematology / OncologyFocusAcute Myeloid Leukemia Research+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026PaymentsNot attributedNIH funding2009–2026Why? →

Marina Konopleva is Professor of Oncology (Medical Oncology) and Molecular Pharmacology / Cell Biology; Director, Leukemia Program; Co-Director, Blood Cancer Institute (Translational Blood Cancer Institute), Montefiore Einstein Comprehensive Cancer Center; Miriam Mandel Faculty Scholar in Cancer Research at Albert Einstein College of Medicine. OpenAlex indexes 2,096 publications with 71,749 citations (h-index 132); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.

Data verified 1 Sept 2026

Overview

Updated 14 Oct 2026

Marina Konopleva is Professor of Oncology (Medical Oncology) and Molecular Pharmacology / Cell Biology at Albert Einstein College of Medicine / Montefiore Einstein Comprehensive Cancer Center. The public record shows 2,096 publications with 71,749 citations (h-index 132), centered on Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 8 registered clinical trials, 12 NIH-funded awards (2009–2026).

  • Most recent indexed publication: 2026 · Blood
  • Top research focus: Acute Myeloid Leukemia Research
  • 8 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Leukemia (AML/ALL/CML/CLL)8 trialsLeukemia, Myeloid, Acute3 trialsLeukemia, Lymphoid2 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma2 trialsMDS / MPN1 trialLeukemia, Lymphocytic, Chronic, B-Cell1 trialPrimary Myelofibrosis1 trialLeukemia, Erythroblastic, Acute1 trialPhiladelphia Chromosome1 trial

Research focus

OpenAlex concept fingerprint
Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchChronic Lymphocytic Leukemia ResearchCAR-T cell therapy research

Drugs & molecules

across trials, industry payments and publications
CytarabineClinical trials2Industry payments—Publications4BlinatumomabClinical trials1Industry payments—Publications2CyclophosphamideClinical trials1Industry payments—Publications1FludarabineClinical trials1Industry payments—Publications1G-CSFClinical trials1Industry payments—Publications1IdarubicinClinical trials1Industry payments—Publications1PlerixaforClinical trials1Industry payments—Publications1VincristineClinical trials1Industry payments—Publications16-MethylprednisoneClinical trials1Industry payments—Publications—Akt Inhibitor MK2206Clinical trials1Industry payments—Publications—AsciminibClinical trials1Industry payments—Publications—ATGClinical trials1Industry payments—Publications—

Works with

trial sponsors and companies reporting payments
M.D. Anderson Cancer CenterClinical trials6Industry payments—National Cancer Institute (NCI)Clinical trials1Industry payments—Threshold PharmaceuticalsClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
2,096publications

Distinct works indexed by OpenAlex, matched via ORCID; 147 in PubMed.

71,749citations

Total citations across indexed works.

132h-index

Hirsch index (OpenAlex). i10-index 746.

Clinical & industry

trials, payments and federal funding
8clinical trials

Investigator role on registered studies.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

12NIH grants · 2009–2026

Federally funded research awards.

View funding ↓

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

An office address from a public listing. This research profile has no federal registry record to draw from.

Office address

Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, 1300 Morris Park Avenue, Ullmann Building 915, Bronx, NY 10461

From the cited public source.Collected 14 Oct 2026.View source ↗

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:

All 8 trial records: search, sort and filter.Explore →

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

Updated 14 Oct 2026

12 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:

All 61 award records: search, sort and filter.Explore →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 147 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
    2,782 citations2020
    doi.org ↗
  2. 02
    Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
    1,854 citations2018
    doi.org ↗
  3. 03
    Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
    1,376 citations2014
    doi.org ↗
  4. 04
    Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
    1,056 citations2016
    doi.org ↗
  5. 05
    Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia
    1,011 citations2006
    doi.org ↗
All 2,096 cited works: search, sort and filter.Explore →

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Hagop M. Kantarjian1013Michael Andreeff802Farhad Ravandi744Elias Jabbour685Guillermo Garcia‐Manero676Tapan M. Kadia647Courtney D. DiNardo617Gautam Borthakur610Naval Daver569Jörge E. Cortes530Naveen Pemmaraju489Nicholas J. Short373Nitin Jain352Koji Sasaki308Koichi Takahashi298Steven M. Kornblau275Sherry Pierce224Musa Yılmaz198Zeev Estrov191Yesid Alvarado185Ghayas C. Issa179Vivian Ruvolo178Guillermo Montalban‐Bravo176William G. Wierda165Susan O’Brien162Keyur P. Patel158Sanam Loghavi147Abhishek Maiti135Teresa McQueen130Prithviraj Bose121Joseph D. Khoury119Qi Zhang119Alessandra Ferrajoli118Yoko Tabe116Jan A. Burger116Lucia Masárová115Maro Ohanian114Rebecca Garris108Xuelin Huang107Natalia Baran107

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/marina-konopleva-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/marina-y-konopleva-md-phd-5bb559407

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • X / Twitter

    x.com/mkonople

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/EinsteinCollegeofMedicine/posts/marina-konopleva-md-phd-has-joined-forces-with-break-through-cancer-a-collaborat/962816475879208

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Facebook

    facebook.com/montefioremedicalcenter/videos/marina-konopleva-md-phd-director-of-montefiore-einsteins-leukemia-program-and-co/2596339624066434

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Instagram

    instagram.com/einsteinmed/p/DCSBTm-pcaf

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • Instagram

    instagram.com/montefiorehealthsystem/reel/DDH4470J0Ch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • Other

    oncodaily.com/dialogues/62114

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • LinkedIn

    LinkedIn profile listed under prior title "Assist Prof - MD Anderson Cancer Center" (stale/pre-2022 legacy profile) -- independently corroborated as stale by a colleague (Nitin Jain)'s July 2 …

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • X / Twitter

    Referenced/tagged on Twitter/X by conference attendees discussing her research talks

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Director

    Leukemia Program, Montefiore Einstein Comprehensive Cancer Center (MECCC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →montefioreeinstein.org ↗
  • Co-Director

    Blood Cancer Institute (Translational Blood Cancer Institute), MECCC

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.montefioreeinstein.org ↗
  • Vice-Chair

    Alliance for Clinical Trials in Oncology's Leukemia Committee for Correlative Science / Correlative Science Leader

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →montefioreeinsteinnow.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Formerly Professor

    Department of Leukemia, University of Texas MD Anderson Cancer Center (prior institution; departed ~July 2022 …

    2022
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Member

    Scientific Advisory Board, Science Translational Medicine (AAAS)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →science.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.